Proinflammatory CD20 + T Cells are Differentially Affected by Multiple Sclerosis Therapeutics-Reference-Cited by-同舟云学术

Proinflammatory CD20 + T Cells are Differentially Affected by Multiple Sclerosis Therapeutics

Published:2021-10-02 Issue:5 Volume:90 Page:834-839
ISSN:0364-5134
Container-title:Annals of Neurology
language:en
Short-container-title:Ann Neurol

Author:

Quendt Corinna¹,Ochs Jasmin²,Häusser‐Kinzel Silke²,Häusler Darius²,Weber Martin S.¹²³^ORCID

Affiliation:

1. Department of Neurology University Medical Center Göttingen Germany

2. Institute of Neuropathology University Medical Center Göttingen Germany

3. Fraunhofer Institute for Translational Medicine and Pharmacology ITMP Göttingen: Robert‐Koch‐Straße 40 Göttingen Germany

Funder

Deutsche Forschungsgemeinschaft

National Multiple Sclerosis Society

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ana.26216

Reference17 articles.

1. Immunology of Multiple Sclerosis

2. Expression of cell surface markers after human B lymphocyte activation.

3. Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients

4. The MS4A family: counting past 1, 2 and 3

5. OchsJ NissimovN KochJ et al.CD20+ T cells emerge from pathogenic B cell‐ T cell interaction. Poster presented at: 8th JOINT ACTRIMS‐ECTRIMS MEETING; 11‐13 September2020.

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Knowledge about CD3+CD20+ T Cells in Patients with Multiple Sclerosis;International Journal of Molecular Sciences;2024-08-18

2. Role of CD20<sup>+</sup>T lymphocytes in the pathogenesis of multiple sclerosis;Medical Immunology (Russia);2024-07-26

3. Role of CD20+ T cells in cancer, autoimmunity and obesity;Journal of Endocrinology;2024-01-18

4. A biphenotypic lymphocyte subset displays both T- and B-cell functionalities;Communications Biology;2024-01-05

5. Clinical efficacy of anti-CD20 antibodies in neurological and neuromuscular diseases;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024